Literature DB >> 1898596

Ig H and L chain contributions to autoimmune specificities.

M Z Radic1, M A Mascelli, J Erikson, H Shan, M Weigert.   

Abstract

An Ig H chain expression vector has been constructed by using the V region of 3H9, an antibody that binds ssDNA, dsDNA, and cardiolipin. The H chain construct was transfected into six hybridoma cell lines expressing Ig L chains. All resulting H and L chain combinations had at least some affinity for ssDNA, whereas five also bound dsDNA to a similar degree as 3H9. The loss of dsDNA binding was correlated with a single amino acid difference between two V kappa 8 L chains. A further characteristic of 3H9, its immunofluorescent staining pattern, was shared by four of the recombinant antibodies, whereas its specificity for cardiolipin was shared with five. The transfections reported here show that a V kappa 3 L chain confers specificity for an RNA-associated epitope and that a V kappa 21E L chain prevents cardiolipin binding. These experiments suggest that the 3H9 H chain contributes essential determinants required for binding to DNA as well as cardiolipin but that L chains can modulate or prevent this binding. L chains may also expand the specificity of a recombinant antibody.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1898596

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  68 in total

Review 1.  Receptor selection in B and T lymphocytes.

Authors:  D Nemazee
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 2.  The regulation and activation potential of autoreactive B cells.

Authors:  Michele L Fields; Su-Jean Seo; Simone A Nish; Jeff H Tsai; Andrew J Caton; Jan Erikson
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

3.  Activation of diverse repertoires of autoreactive T cells enhances the loss of anti-dsDNA B cell tolerance.

Authors:  Brian W Busser; Brigette S Adair; Jan Erikson; Terri M Laufer
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

4.  Analysis of immunoglobulin variable region genes of a human IgM anti-myeloperoxidase antibody derived from a patient with vasculitis.

Authors:  C Longhurst; M R Ehrenstein; B Leaker; F K Stevenson; M Spellerberg; C Chapman; D Latchmen; D A Isenberg; G Cambridge
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

5.  Nur77 Links Chronic Antigen Stimulation to B Cell Tolerance by Restricting the Survival of Self-Reactive B Cells in the Periphery.

Authors:  Corey Tan; James L Mueller; Mark Noviski; John Huizar; Denise Lau; Alexandra Dubinin; Ari Molofsky; Patrick C Wilson; Julie Zikherman
Journal:  J Immunol       Date:  2019-04-08       Impact factor: 5.422

6.  Specific recognition of a dsDNA sequence motif by an immunoglobulin VH homodimer.

Authors:  Hulin Jin; Jorge Sepúlveda; Oscar R Burrone
Journal:  Protein Sci       Date:  2004-12       Impact factor: 6.725

7.  Divergent members of a single autoreactive B cell clone retain specificity for apoptotic blebs.

Authors:  Indira Neeli; Mekel M Richardson; Salar N Khan; Danielle Nicolo; Marc Monestier; Marko Z Radic
Journal:  Mol Immunol       Date:  2006-11-03       Impact factor: 4.407

8.  Editing and escape from editing in anti-DNA B cells.

Authors:  Salar N Khan; Esther J Witsch; Noah G Goodman; Anil K Panigrahi; Ching Chen; Yufei Jiang; Amy M Cline; Jan Erikson; Martin Weigert; Eline T Luning Prak; Marko Radic
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-29       Impact factor: 11.205

9.  VH and V kappa segment structure of anti-insulin IgG autoantibodies in patients with insulin-dependent diabetes mellitus. Evidence for somatic selection.

Authors:  H Ikematsu; Y Ichiyoshi; E W Schettino; M Nakamura; P Casali
Journal:  J Immunol       Date:  1994-02-01       Impact factor: 5.422

10.  Pathogenic autoantibodies in systemic lupus erythematosus are derived from both self-reactive and non-self-reactive B cells.

Authors:  Jie Zhang; Annett M Jacobi; Tao Wang; Betty Diamond
Journal:  Mol Med       Date:  2008-07-30       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.